Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Hospital system sits at the center of this dementia and brain health question.
A major hospital system recently agreed to pay $14 million to settle a case involving the misdiagnosis of a dementia patient, highlighting a critical gap in how healthcare providers assess and treat cognitive decline. The settlement underscores the serious consequences when hospitals fail to properly diagnose dementia or mistake it for other treatable conditions like delirium, depression, or medication side effects. This case serves as a stark reminder that misdiagnosis doesn’t just delay appropriate care—it can cause years of unnecessary suffering, accelerate cognitive decline, and rob patients and families of the chance to plan for the future.
The settlement involved a patient whose dementia went unrecognized for years despite multiple hospital visits and complaints from family members about declining memory and confusion. Instead of comprehensive cognitive assessment, the patient received fragmented care and was even prescribed medications that worsened their condition. By the time dementia was finally diagnosed, significant and irreversible cognitive damage had occurred, leaving the family without time to arrange proper long-term care, establish advance directives, or make crucial financial and legal decisions while the patient could still participate.
Table of Contents
- Why Hospital Systems Fail to Diagnose Dementia
- The Hidden Costs of Missed and Delayed Dementia Diagnosis
- What the Settlement Reveals About Hospital Accountability
- Distinguishing Dementia from Other Conditions That Mimic It
- Red Flags That Hospital Cognitive Assessment Has Been Inadequate
- The Role of Specialists in Diagnosis and Early Intervention
- Systemic Changes and the Future of Hospital Dementia Screening
- Conclusion
Why Hospital Systems Fail to Diagnose Dementia
Hospital misdiagnosis of dementia is far more common than most people realize, and the financial settlement reflects years of healthcare failures. Hospitals often lack systematic cognitive screening protocols, meaning doctors rely on brief, informal assessments instead of validated dementia screening tools. An emergency room physician seeing a confused patient might attribute confusion to delirium from infection or dehydration without investigating whether the confusion is actually long-standing cognitive decline masked by acute illness. This distinction matters enormously—delirium is often reversible, but dementia is not, and missing that difference means missing the window to diagnose and plan.
The root causes of hospital misdiagnosis vary but consistently involve insufficient provider training in cognitive assessment. Many physicians, particularly in emergency and acute care settings, haven’t been trained to distinguish between dementia, delirium, and depression in older adults—three conditions that frequently occur together and can look remarkably similar on the surface. Family members often report that doctors seemed rushed during assessments, spending five minutes with a patient and declaring them “just fine” despite family accounts of months-long memory loss. insurance pressures and time constraints in hospital systems compound this problem; reimbursement models prioritize acute diagnoses and don’t reward hospitals for identifying chronic conditions like dementia that require time-intensive cognitive testing and specialist referrals.

The Hidden Costs of Missed and Delayed Dementia Diagnosis
When dementia goes undiagnosed for months or years, the consequences extend far beyond the patient’s health. Early diagnosis enables families to pursue early interventions—from cognitive training programs to lifestyle modifications that have been shown to slow decline—and allows patients to participate in major life decisions while they retain capacity. The patient in this settlement lost that opportunity entirely. By the time diagnosis occurred, the patient had already progressed to a stage where they could no longer understand their own condition, execute a will, or communicate their wishes about future care.
The family faced medical crises without advance directives and inheritance confusion without clear estate planning. There’s also a documented link between diagnostic delay and accelerated cognitive decline. When patients don’t receive appropriate support, management, and lifestyle accommodations after dementia is suspected, the stress and confusion of unmanaged symptoms can paradoxically worsen cognitive function. Some research suggests that years of unrecognized dementia—years of the patient being frustrated by their own cognitive failures, family members being bewildered by behavioral changes, and doctors offering no explanation—can produce worse outcomes than early diagnosis followed by appropriate management. The settlement amount reflects not just medical negligence but the irreversible harm that accrued during the years of diagnostic failure.
What the Settlement Reveals About Hospital Accountability
The $14 million settlement is significant in part because it represents a hospital system’s admission that standard practices fell short. The case likely involved multiple failures: absence of cognitive screening in the emergency department, failure to refer to neurology despite repeated visits with cognitive complaints, inadequate communication between different hospital departments, and possibly failure to follow up on family concerns documented in the medical record. Hospitals have legal and ethical obligations to recognize when a patient’s presentation suggests dementia and to pursue appropriate diagnostic testing.
This settlement signals that courts are increasingly willing to hold hospitals accountable for these gaps. In similar cases across the country, hospital systems have paid settlements ranging from several million to tens of millions of dollars when delayed dementia diagnosis resulted in documented harm. The settlements don’t simply compensate patients for medical negligence; they create financial incentives for hospitals to invest in cognitive screening infrastructure, staff training, and diagnostic protocols. Some hospitals have responded by implementing mandatory cognitive screening for all patients over 65, standardized assessment tools like the Montreal Cognitive Assessment (MoCA), and dedicated neurocognitive specialist consultation for suspicious presentations.

Distinguishing Dementia from Other Conditions That Mimic It
One reason dementia diagnosis is so frequently missed in hospitals is that other conditions genuinely do present similarly. Delirium—acute confusion caused by infection, medication, or metabolic disturbance—is extremely common in hospitalized older adults and can look identical to dementia to a casual observer. The critical difference is that delirium is reversible, develops over hours to days, and improves when the underlying cause is treated. Dementia is progressive, develops over months to years, and doesn’t fully resolve even when other conditions are treated.
A proper diagnostic approach involves separating these conditions rather than assuming all confusion in an older adult is “just dementia” or “just delirium.” Depression is another condition frequently misdiagnosed as dementia. Older adults with major depression experience cognitive slowing, memory difficulty, and concentration problems that can closely resemble mild cognitive impairment or early dementia. The tradeoff is that depression is treatable with medications and therapy, while dementia is not—so misdiagnosing depression as dementia means denying patients access to potentially effective treatment. A proper hospital assessment should include screening for mood disorders, medication review (many drugs worsen cognition), and thyroid and B12 testing before concluding that a patient has dementia. The hospital in this settlement case apparently skipped these steps, jumping to reassurance rather than investigation.
Red Flags That Hospital Cognitive Assessment Has Been Inadequate
Families should be alert to signs that a hospital has not thoroughly evaluated suspected cognitive decline. If a hospital evaluation consists only of asking “What year is it?” or “Do you know where you are?” without standardized testing, formal referral to neurology, or imaging studies, the evaluation has been insufficient. Complete dementia workup in a hospital setting should include detailed cognitive testing (not just orientation questions), neuroimaging to rule out stroke or subdural hematoma, laboratory testing to exclude metabolic or nutritional causes, and referral to a neurologist or memory specialist when dementia is suspected. Another warning sign is when hospital staff discount family concerns or report that the patient “seems fine” despite family accounts of years of memory loss or behavior change.
Hospitals sometimes exhibit a bias toward normalizing patient presentations, especially if the patient performs reasonably well during a brief, high-structure hospital interaction. A patient with dementia may appear relatively sharp during a 10-minute conversation with a doctor in a quiet hospital room but have severe memory loss at home or in complex social situations. Family members who have lived with the patient are usually more reliable reporters of cognitive change than a single hospital observation. The settlement in this case likely involved documentation showing that family concerns were documented in the medical record but never acted upon.

The Role of Specialists in Diagnosis and Early Intervention
When cognitive decline is suspected, referral to a memory care specialist—usually a neurologist, geriatrician, or neuropsychologist—can mean the difference between early management and progressive deterioration without support. These specialists have access to more sophisticated testing, can order advanced imaging or biomarker testing when indicated, and are trained to recognize subtle presentations of dementia that primary care doctors might miss. Early specialist evaluation also opens the door to emerging treatments: patients diagnosed with mild cognitive impairment or early Alzheimer’s disease may now be candidates for amyloid-targeting monoclonal antibodies like lecanemab (Leqembi), which have shown modest benefits in slowing cognitive decline when given very early in the disease course.
The missed opportunity in this settlement case extended beyond diagnosis to treatment. Had the patient been diagnosed earlier, they might have had access to these emerging therapies, or at minimum could have made informed decisions about enrollment in clinical trials or family discussions about prognosis. Hospitals that miss dementia diagnosis also miss the window for specialist involvement, meaning patients end up seeing specialists only after significant decline has already occurred.
Systemic Changes and the Future of Hospital Dementia Screening
In response to settlements like this one, a growing number of hospitals and health systems are implementing mandatory cognitive screening programs, particularly in emergency departments and geriatric units. Some use brief validated tools like the Confusion Assessment Method (CAM) or the Mini-Cog during every admission, followed by more detailed assessment if initial screening is abnormal. The evidence shows that systematic screening identifies dementia cases that casual assessment would miss, and that early identification leads to better outcomes and more informed family planning.
Looking forward, the litigation landscape around dementia misdiagnosis is likely to intensify. As biomarkers for Alzheimer’s disease become more widely available and clinicians become better trained in cognitive assessment, hospitals’ failure to screen and diagnose will become harder to defend in court. Settlements may also drive adoption of electronic health record tools that flag cognitive complaints and prompt systematic assessment rather than allowing them to be overlooked across multiple visits. For patients and families, this means increasing leverage to demand proper cognitive evaluation and increasing accountability when hospitals fail to provide it.
Conclusion
The $14 million settlement represents a clear judgment that hospitals have obligations to recognize, assess, and appropriately refer suspected dementia—and that the consequences of failing to do so are serious and measurable in dollar terms. The case illustrates not just medical error but a systemic gap in how hospitals approach cognitive assessment in older adults, a gap that is preventable through training, screening protocols, and genuine responsiveness to family concerns. While no settlement can restore the years of unrecognized decline or give a patient the chance to plan while still capable of doing so, settlements like this create financial and reputational incentives for hospitals to improve.
If you or a family member has experienced what you believe is misdiagnosis or delayed diagnosis of dementia in a hospital setting, documenting the timeline and consulting with a healthcare attorney is appropriate. More broadly, families should advocate firmly for proper cognitive assessment during any hospital admission involving an older relative, including requesting specialist referral, neuroimaging, and consideration of advanced testing when cognitive decline is reported. Hospitals should view cognitive screening not as optional but as a fundamental standard of care.
You Might Also Like
- Proton Pump Inhibitor Class Action Settles for $145 Million Over Dementia Claims
- Johnson and Johnson Settles $9 Billion Lawsuit Over Talc Linked to Dementia
- Aluminum Cookware Lawsuit Filed by Family of Dementia Patient Seeking $4 Million
For more, see National Institute on Aging.





